Gene · 2195
Papers4,590
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 4,590
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive genomic profiling of colorectal cancer patients reveals differences in mutational landscapes among clinical and pathological subgroups. | Front Oncol | 2022 | 36439454 | PubTator, text mining | PubMed |
| Signatures of Breast Cancer Progression in the Blood: What Could Be Learned from Circulating Tumor Cell Transcriptomes. | Cancers (Basel) | 2022 | 36428760 | PubTator, text mining | PubMed |
| Fatty Acid Synthase Mutations Predict Favorable Immune Checkpoint Inhibitor Outcome and Response in Melanoma and Non-Small Cell Lung Cancer Patients. | Cancers (Basel) | 2022 | 36428733 | PubTator, text mining | PubMed |
| Molecular Biomarkers of Malignant Transformation in Head and Neck Dysplasia. | Cancers (Basel) | 2022 | 36428690 | PubTator, text mining | PubMed |
| PTC124 Rescues Nonsense Mutation of Two Tumor Suppressor Genes NOTCH1 and FAT1 to Repress HNSCC Cell Proliferation. | Biomedicines | 2022 | 36428516 | PubTator, text mining | PubMed |
| Molecular subtyping of esophageal squamous cell carcinoma by large-scale transcriptional profiling: Characterization, therapeutic targets, and prognostic value. | Front Genet | 2022 | 36425064 | PubTator, text mining | PubMed |
| Temporal and spatial characteristics of tumor evolution in a mouse model of oral squamous cell carcinoma. | BMC Cancer | 2022 | 36424557 | PubTator, text mining | PubMed |
| Tertiary lymphoid structure patterns aid in identification of tumor microenvironment infiltration and selection of therapeutic agents in bladder cancer. | Front Immunol | 2022 | 36420257 | PubTator, text mining | PubMed |
| Cooling down with Entresto. Can sacubitril/valsartan combination enhance browning more than coldness? | Diabetol Metab Syndr | 2022 | 36419097 | PubTator, text mining | PubMed |
| Study on the central neural pathway and the relationship between the heart and small intestine via a dual neural tracer. | PLoS One | 2022 | 36413525 | PubTator, text mining | PubMed |
| Editorial: Epigenetics and molecular genetics of rare tumors. | Front Oncol | 2022 | 36408168 | PubTator, text mining | PubMed |
| Membranous nephropathy: Clearer pathology and mechanisms identify potential strategies for treatment. | Front Immunol | 2022 | 36405681 | PubTator, text mining | PubMed |
| Preference for ugly faces? -A cognitive study of attentional and memorial biases toward facial information among young females with facial dissatisfaction. | Front Psychol | 2022 | 36405166 | PubTator, text mining | PubMed |
| Chronic oligodendrocyte injury in central nervous system pathologies. | Commun Biol | 2022 | 36402839 | PubTator, text mining | PubMed |
| How people wake up is associated with previous night's sleep together with physical activity and food intake. | Nat Commun | 2022 | 36402781 | PubTator, text mining | PubMed |
| Characterization of HCI-EC-23 a novel estrogen- and progesterone-responsive endometrial cancer cell line. | Sci Rep | 2022 | 36396974 | PubTator, text mining | PubMed |
| A genome-wide cell-free DNA methylation analysis identifies an episignature associated with metastatic luminal B breast cancer. | Front Cell Dev Biol | 2022 | 36393855 | PubTator, text mining | PubMed |
| Identification of six hub genes in mantle cell lymphoma patients with BTKi resistance. | Ann Transl Med | 2022 | 36388812 | PubTator, text mining | PubMed |
| A case report of primary cardiac angiosarcoma with DNMT3A gene mutation. | Front Oncol | 2022 | 36387074 | PubTator, text mining | PubMed |
| The first Japanese case of intraductal cancer of the prostate with checkpoint kinase 2 mutation. | Asian J Urol | 2022 | 36381593 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2195/papers?page=53